Ongoing research is focused on elucidating the complex regulatory networks involving CAR and its interaction with other nuclear receptors. Advances in molecular biology techniques, such as CRISPR-Cas9 and high-throughput screening, are providing deeper insights into CAR's role in toxicology. These studies aim to develop novel therapeutic strategies that target CAR pathways to mitigate the adverse effects of drugs and toxicants.
